Atrial fibrillation (AF) is the most common heart rhythm disorder, affecting millions of people worldwide.As it affects more and more people, many questions remain unanswered about why AF develops and progresses in some individuals. Improved understanding of the biological mechanisms and risk factors underlying AF is helping to drive new approaches to its prevention and treatment.
In this seminar, two experts will talk about their research on atrial fibrillation and answer your questions:
Professor Barbara Casadei is Head of the National Heart and Lung Institute (NHLI) at Imperiaand a British Heart Foundation Professor of Cardiovascular Medicine. Professor Casadei will talk about her research on understanding the mechanisms and determinants of atrial fibrillation.
Professor Prapa Kanagaratnam is Professor of Cardiology in the National Heart and Lung Institute and a Consultant Cardiologist at ImperiaCollege Healthcare NHS Trust. Professor Kanagaratnam will talk about his research on advancing new treatments for atrial fibrillation.